Literature DB >> 25000896

Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology.

Solomon L Woldu1, Aaron C Weinberg, Arindam RoyChoudhury, Herbert Chase, Sean D Kalloo, James M McKiernan, G Joel DeCastro.   

Abstract

PURPOSE: End-stage renal disease (ESRD) and acquired renal cystic disease associated with dialysis are known risk factors of papillary renal cell carcinoma (pRCC); however, it is not known whether renal insufficiency alone is a risk factor for pRCC. Our aim was to test whether renal insufficiency is associated with an increased preponderance of pRCC.
METHODS: Retrospective review of institutional database to identify all patients who underwent extirpative renal surgery for renal cell carcinoma (RCC) with complete records from 1992 to 2012. We excluded those patients with preoperative ESRD as defined by GFR < 15 mL/min/1.73 m(2). The dependent variable was histologic RCC subtype. Independent variables included demographic data, comorbidities, and renal functional data. Multivariate analysis by binary logistic regression was used to determine factors that independently were associated with pRCC development.
RESULTS: A total of 1,226 patients met inclusion criteria, of which 15 % were pRCC. There was a positive association between likelihood of pRCC histology of RCC and increasing preoperative chronic kidney disease (CKD) stage (p = 0.021). Multivariate regression analysis indicated that male gender, race, and declining renal function categorized both by GFR and CKD stage were independently associated with a higher likelihood of pRCC histology as compared to other RCC histology.
CONCLUSIONS: Within a large cohort of patients with a diagnosis of RCC, declining renal function was independently associated with an increased likelihood of pRCC histology. This finding and the available molecular evidence indicating protein expression similarity between pRCC and resident stem cells, which appear to be upregulated with kidney damage, suggest a possible causal relationship between renal injury and pRCC.

Entities:  

Mesh:

Year:  2014        PMID: 25000896     DOI: 10.1007/s11255-014-0780-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

Authors:  Pei-Hsuan Weng; Kuan-Yu Hung; Hsien-Liang Huang; Jen-Hau Chen; Pei-Kun Sung; Kuo-Chin Huang
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury.

Authors:  Maria Lucia Angelotti; Elisa Ronconi; Lara Ballerini; Anna Peired; Benedetta Mazzinghi; Costanza Sagrinati; Eliana Parente; Mauro Gacci; Marco Carini; Mario Rotondi; Agnes B Fogo; Elena Lazzeri; Laura Lasagni; Paola Romagnani
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

Review 3.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

4.  Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis.

Authors:  Kyungeun Kim; Bong-Hee Park; Hyojin Ihm; Kyung Min Kim; Jinuk Jeong; Jai Won Chang; Yong Mee Cho
Journal:  Histol Histopathol       Date:  2011-02       Impact factor: 2.303

5.  Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; K Junker; N Nakaigawa; T Kinjerski; G Weirich; M Miller; I Lubensky; H P Neumann; H Brauch; J Decker; C Vocke; J A Brown; R Jenkins; S Richard; U Bergerheim; B Gerrard; M Dean; W M Linehan; B Zbar
Journal:  Oncogene       Date:  1999-04-08       Impact factor: 9.867

6.  Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.

Authors:  Laura S Schmidt; Michael L Nickerson; Debora Angeloni; Gladys M Glenn; McClellan M Walther; Paul S Albert; Michelle B Warren; Peter L Choyke; Carlos A Torres-Cabala; Maria J Merino; Joan Brunet; Victòria Bérez; Joan Borràs; Giovanni Sesia; Lindsay Middelton; John L Phillips; Catherine Stolle; Berton Zbar; Stephen E Pautler; W Marston Linehan
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 7.  Renal cell carcinoma.

Authors:  Brian I Rini; Steven C Campbell; Bernard Escudier
Journal:  Lancet       Date:  2009-03-05       Impact factor: 79.321

8.  The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.

Authors:  Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Julie J Ruterbusch; Brian M Shuch; Sara Karami; Nathaniel Rothman; Sholom Wacholder; Barry I Graubard; Joanne S Colt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2012-11-21       Impact factor: 2.506

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.

Authors:  John H Stewart; Gherardo Buccianti; Lawrence Agodoa; Ryszard Gellert; Margaret R E McCredie; Albert B Lowenfels; Alex P S Disney; Robert A Wolfe; Peter Boyle; Patrick Maisonneuve
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  7 in total

1.  Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center.

Authors:  Onder Kara; Hiury S Andrade; Homayoun Zargar; Oktay Akca; Matthew J Maurice; Peter A Caputo; Daniel Ramirez; Ercan Malkoc; Charles S Modlin; Jihad H Kaouk
Journal:  J Robot Surg       Date:  2016-02-09

2.  Renal cell cancer after kidney transplantation.

Authors:  Dennis Kleine-Döpke; Matthias Oelke; Anke Schwarz; Ysabell Schwager; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2018-07-12       Impact factor: 3.445

3.  Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrian Y Tan; Tuo Zhang; Alber Michaeel; Jon Blumenfeld; Genyan Liu; Wanying Zhang; Zhengmao Zhang; Yi Zhu; Lior Rennert; Che Martin; Jenny Xiang; Steven P Salvatore; Brian D Robinson; Sandip Kapur; Stephanie Donahue; Warren O Bobb; Hanna Rennert
Journal:  J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 10.121

4.  Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08.

Authors:  Ki Hyang Kim; Joo Hoon Kim; Ji Young Lee; Hyo Song Kim; Su Jin Heo; Ji Hyung Kim; Ho Young Kim; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2016-02-12       Impact factor: 4.679

5.  Prognostic Value of Pre-operative Renal Insufficiency in Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Jian Cao; Xiaokun Zhao; Zhaohui Zhong; Lei Zhang; Xuan Zhu; Ran Xu
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

6.  Multimodality Imaging Characteristics of the Common Renal Cell Carcinoma Subtypes: An Analysis of 544 Pathologically Proven Tumors.

Authors:  Winnie Fu; Guan Huang; Zaahir Moloo; Safwat Girgis; Vimal H Patel; Gavin Low
Journal:  J Clin Imaging Sci       Date:  2016-12-29

7.  The genomic landscape of pediatric renal cell carcinomas.

Authors:  Pengbo Beck; Barbara Selle; Lukas Madenach; David T W Jones; Christian Vokuhl; Apurva Gopisetty; Arash Nabbi; Ines B Brecht; Martin Ebinger; Jenny Wegert; Norbert Graf; Manfred Gessler; Stefan M Pfister; Natalie Jäger
Journal:  iScience       Date:  2022-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.